tradingkey.logo
tradingkey.logo
Search

Virax Biolabs Group Ltd

VRAX
Add to Watchlist
2.620USD
-0.180-6.43%
Close 07-31 16:00ETQuotes delayed by 15 min
11.38MMarket Cap
LossP/E TTM

VRAX Financials

See Virax Biolabs Group Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Virax Biolabs Group Ltd Earnings Date

Latest Release
Jul 6, 2026
EPS / Forecast
-12.64/--
Revenue / Forecast
12.42K/--
Period
FY2026 Earnings
Revenue(YoY)
12.42K
96.22%
EPS(YoY)
-12.64
-677.64%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H2
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022Q4
FY2022Q2
Financial Indicators
EPS
---0.76
---0.89
----
----
----
----
---1.50
----
Revenue
----
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
----
----
Net Profit
----
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
----
----
Net Margin
---240251.67%
---55654.43%
----
----
----
----
----
----
Gross Margin
---3381.20%
---130.71%
----
----
----
----
----
----
Debt to assets ratio
--5.87%
--6.39%
----
----
----
----
----
----
Revenue
----
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
----
----
Operating profit
----
-6.38%-2.88M
20.79%-3.40M
-87.86%-2.71M
---4.29M
---1.44M
----
----
Net Profit
----
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
----
----
Current assets
11.72%4.89M
34.54%8.03M
-54.53%4.38M
12.69%5.97M
--9.63M
--5.30M
--48.71K
--43.03K
Total current liabilities
298.70%673.21K
-11.82%693.97K
-81.41%168.85K
-31.11%787.02K
--908.40K
--1.14M
--1.25M
--1.05M
Total assets
17.19%6.43M
34.41%9.44M
-44.11%5.48M
32.58%7.03M
--9.81M
--5.30M
--48.71K
--43.03K
Total liabilities
179.48%964.75K
11.64%1.03M
-62.00%345.19K
-19.56%919.05K
--908.40K
--1.14M
--1.25M
--1.05M
Total equity
6.29%5.46M
37.84%8.42M
-42.29%5.14M
46.92%6.11M
--8.90M
--4.16M
---1.20M
---1.00M
Net operating income
----
46.62%-1.92M
-48.11%-2.79M
-56.50%-3.59M
---1.88M
---2.30M
----
----
Net investment
----
64.98%-248.00K
-155.75%-456.27K
---708.18K
---178.40K
----
----
----
Net financing
----
10099.64%5.86M
-74.77%1.73M
-99.16%57.49K
--6.84M
--6.84M
----
----

FAQs

What is the total revenue of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total revenue reached 12.42K, with a year-on-year change of 6.33K.

What are the current assets of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its current assets were 6.83M, with a year-on-year change of 39.54.

What are the total assets of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total assets of Virax Biolabs Group Ltd were 8.32M, with a year-on-year change of 29.53.

What are the total liabilities of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total liabilities of Virax Biolabs Group Ltd were 989.83K, with a year-on-year change of 2.60.

What is the total equity of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total equity of Virax Biolabs Group Ltd was 7.33M, with a year-on-year change of 34.29.

What is the net operating income of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net operating income of Virax Biolabs Group Ltd was -6.40M, with a year-on-year change of -3.84.

What is the net investment of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net investment of Virax Biolabs Group Ltd was -255.83K, with a year-on-year change of 57.64.

What is the net financing of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net financing of Virax Biolabs Group Ltd was 7.09M, with a year-on-year change of 22.05.

What is the Earnings Per Share (EPS) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Earnings Per Share (EPS) was -12.64, with a year-on-year change of -677.64.

What is the net income of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net income was -5.02M, with a year-on-year change of 17.12.

What is the net margin of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net profit margin was -40507.00, with a year-on-year change of 57.73.

What is the gross margin of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its gross margin was 61.90, with a year-on-year change of 107.38.

What is the debt-to-asset ratio of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its debt-to-asset ratio was 4.98, with a year-on-year change of -15.14.

What is the Return on Equity (ROE) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Return on Equity (ROE) was -75.70, with a year-on-year change of 30.92.

What is the Return on Assets (ROA) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Return on Assets (ROA) was -68.23, with a year-on-year change of 33.03.

What is the operating profit of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its operating profit was -6.40M, with a year-on-year change of -3.84.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.